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Abstract
Upon activation by light, rhodopsin is subject to phosphorylation by rhodopsin kinase at serine and threonine residues in
the carboxyl terminal region of the protein. A 19 amino acid peptide that corresponds to the carboxyl terminal end of
rhodopsin (residues 330^348) and contains these phosphorylation sites was synthesized. The structure of this peptide was
determined using two-dimensional proton NMR. The structure of this peptide was similar to that determined for this region
in peptides corresponding to the carboxyl 33 and 43 amino acids of rhodopsin. The effect of phosphorylation on the structure
of the carboxyl terminal domain of rhodopsin was determined by solving the solution structures of the peptide containing
residues 330^348 with phosphorylation at one (residue 343), three (residues 343, 338, and 334) and seven residues (residues
334, 335, 336, 338, 340, 342, 343). These data indicate that the major structural change occurs upon phosphorylation of the
first residue, and that an additional structural change occurs with seven phosphates. ß 1999 Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
At low light levels, retinal rod cells are responsible
for visual signal transduction. The initial events of
visual transduction take place on the disk mem-
branes which are densely stacked along the length
of the outer segments of rod photoreceptor cells.
Upon absorption of light, the photopigment, rho-
dopsin, goes through a series of spectrally de¢ned
intermediates. The transition of Metarhodopsin I to
Metarhodopsin II allows the G-protein, transducin,
to bind and to initiate the cGMP cascade which cul-
minates in the hydrolysis of cGMP. Reduction in the
concentration of cGMP leads to closure of the plas-
ma membrane Na channels and hyperpolarization
of the plasma membrane.
Following initiation, the transduction cascade
must be terminated. A mechanism of desensitization
is phosphorylation of rhodopsin by rhodopsin kinase
[1^4] followed by arrestin binding. Arrestin binds to
photoactivated rhodopsin only following phospho-
rylation. The binding of arrestin prevents further ac-
tivation of transducin by rhodopsin. As is the case
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with other G-protein receptors, rhodopsin can be-
come phosphorylated at multiple sites after activa-
tion. This phosphorylation of rhodopsin occurs on
the carboxyl terminal domain of the receptor [5].
However the precise roles which speci¢c sites of
phosphorylation may play in visual transduction
are currently under investigation [6^8].
The molecular mechanism of desensitization by
phosphorylation is unknown. However, two mecha-
nisms are possible: (1) phosphorylation may change
the conformation of the protein and thereby inhibit
transducin binding [9]; and (2) phosphorylation will
add negative charge which may inhibit transducin
binding [10]. Furthermore, phosphorylation also pro-
vides a site for activation of arrestin [11], and bind-
ing of arrestin to photoactivated phosphorylated
rhodopsin prevents further activation of transducin
by rhodopsin.
A three dimensional structure of rhodopsin would
allow the e¡ects of phosphorylation to be visualized.
Work is currently in progress on the three dimen-
sional structure of rhodopsin. Electron di¡raction
has been successfully used to determine a low-reso-
lution structure for the bundle of seven transmem-
brane helices of this G-protein receptor [12^14]. Us-
ing two-dimensional homonuclear NMR, we have
determined the structure of the cytoplasmic surface
of this receptor to moderately high resolution [15^
19].
Fig. 1 shows the previously determined structure
of the carboxyl terminal domain. Following absorp-
tion of light by rhodopsin, rhodopsin kinase sequen-
tially phosphorylates serine and threonine residues in
the carboxyl terminal region of rhodopsin. Therefore
it is feasible to investigate the structure of a peptide
which includes all of the sites which become phos-
phorylated under physiological conditions. In this
study, we use two-dimensional homonuclear NMR
to determine the e¡ects of phosphorylation on the
structure of the carboxyl terminal of rhodopsin. It
is ¢rst shown that an unphosphorylated peptide con-
sisting of the carboxyl terminal 19 residues of rho-
Fig. 1. Structure of the carboxyl terminal domain of bovine rhodopsin. Two-dimensional NMR was used to determine the solution
structure of a 43 amino acid peptide (residues 303^348 of rhodopsin). This structure agrees well with structural determinations avail-
able on intact rhodopsin [19]. The 19 amino acid unphosphorylated peptide (330^348 in rhodopsin) whose structure was investigated
in the present work is indicated in this ¢gure by the dark line.
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dopsin (330^348) retained the structural characteris-
tics of the parent peptide (shown in Fig. 1), the 43
amino acid residue carboxyl terminal domain of rho-
dopsin attached to the end of transmembrane helix 7
of this receptor. Phosphorylation of the ¢rst (native)
kinase site produced a conformational change in the
peptide from the unphosphorylated form. Phospho-
rylation at the three serines caused no further con-
formational change from the single phosphorylation.
Phosphorylation at seven sites on the peptide caused
additional structural change.
2. Materials and methods
2.1. Peptide synthesis
Peptides constituting the terminal 19 amino acid
residues of the carboxyl terminal domain of bovine
rhodopsin were studied (residues 330^348; DDEAS-
TTVSKTETSQVAPA). Unphosphorylated peptides
were synthesized using Fmoc-Ala-Pam resin and
the standard DCC/HOBt protocol. Cleavage from
the resin and deprotection employed 95% tri£uoro-
acetic acid/5% H2O for 90 min. Phosphopeptides
were made on Boc-Ala-Pam resin using Boc-O-(di-
phenylphosphono)-serine and -threonine by the
DCC/HOBt protocol. Cleavage and deblocking
were performed in a single step using catalytic hydro-
genolysis in the presence of palladium and platinum
with anhydrous tri£uoroacetic acid as solvent
(Arendt, 1996, no. 2869). The peptides were puri¢ed
by HPLC, and had the appropriate amino acid com-
position and mass.
2.2. NMR spectroscopy
All NMR spectra were accumulated using 3^5 mM
peptide in 10 mM phosphate bu¡er at pH 5.9 on a
Bruker AMX-600 spectrometer at 10‡C. Standard
pulse sequences and phase cycling were employed
to record: in H2O (10% D2O), double quantum ¢l-
tered (DQF) COSY and NOESY (400 ms mixing
time) [20]. All spectra were accumulated in a phase
sensitive manner using time-proportional phase in-
crementation for quadrature detection in F1. Chem-
ical shifts were referenced to a trace amount of in-
ternal methanol and expressed relative to TSP.
2.3. Structure re¢nement
The sequence-speci¢c assignment of the 1H-NMR
spectrum was carried out using standard methods.
Assigned NOE cross peaks were segmented using a
statistical segmentation function and characterized as
strong, medium, and weak corresponding to upper
bounds distance range constraints of 2.7, 3.7 and
5.0 Aî , respectively. Lower bounds between non-
bonded atoms were set to the sum of their van der
Waals radii (approximately 1.8 Aî ). Pseudoatom cor-
rections were added to interproton distance restraints
where necessary [21]. Distance geometry calculations
were carried out using the program DIANA [22]
within the SYBYL 6.4 package (Tripos Software,
St. Louis). First-generation DIANA structures, 150
in total, were optimized from 1 to step 43 with the
inclusion of three REDAC cycles. Energy re¢nement
calculations (restrained minimization/dynamics) were
carried out on the best distance geometry structures
using the SYBYL program implementing the Koll-
man all-atom force ¢eld. Statistics on structures were
obtained from X-plor. These calculations were per-
formed on a Silicon Graphics 4D/440 computer.
3. Results and discussion
Phosphorylation plays a central role in the regula-
tion of protein activity. In this study, the e¡ect of
phosphorylation on the structure of a peptide which
corresponds to the region of rhodopsin phosphoryl-
ated by rhodopsin kinase was investigated. Previous
work has suggested that the conformation of a struc-
tured peptide isolated from a larger protein will re-
£ect the structure of the region of the protein to
which it corresponds [23]. The polypeptide compris-
ing the carboxyl terminal 43 amino acids of rhodop-
sin has a structure that agrees well with all the avail-
able evidence on the structure of that portion of
intact rhodopsin. This peptide structure begins at
its amino terminal with an K-helix that is an exten-
sion of transmembrane helix 7. From the top of the
helix, the structure returns to the membrane surface
at Cys-322 and Cys-323, the sites that are palmitoyl-
ated in native rhodopsin. This portion of the struc-
ture forms the fourth cytoplasmic loop. Further to-
wards the carboxyl terminal a short anti-parallel
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L-sheet is formed. The principal phosphorylation
sites, Thr-336, Ser-338 and Ser-343 are in or near
this L-sheet. Therefore, this region is an important
structural domain with respect to the e¡ects of phos-
phorylation. This anti-parallel L-sheet is also con-
served in the structure of the carboxyl terminal 33
amino acid peptide as previously reported [15].
To investigate the e¡ects of phosphorylation on
the structure of rhodopsin, a peptide consisting of
the carboxyl terminal 19 amino acid residues (resi-
dues 330^348) was synthesized. The length of the
peptide was chosen with the following considera-
tions. The peptide must be long enough to contain
the phosphorylation sites and must also be su⁄-
ciently long to retain a well-de¢ned structure which
re£ects the structure of the intact protein. However,
with increasing length, synthetic di⁄culties mount,
especially for phosphorylated species. This chosen
peptide includes all the residues that form the car-
boxyl terminal L-sheet as well as the phosphorylation
sites.
The solution structure of the 330^348 peptide was
determined by standard homonuclear two-dimen-
sional NMR protocols, as described in Section 2.
From the NOESY map, 240 constraints were ob-
tained: 141 intra-residue, 65 sequential and 34 long
range. Fig. 2A shows the number of constraints per
residue. Fig. 3A shows part of the family of struc-
tures obtained from the DIANA calculations and
after energy minimization, and Fig. 4A shows the
rmsd of the backbone as a function of residue for
that family.
The ¢delity of the structural elements in this pep-
tide to longer peptides was examined by comparing
the structure of the 19 mer to that of peptides con-
sisting of the 43 and 33 carboxyl terminal amino
acids of rhodopsin. The average rmsd values of the
backbone atoms for a superposition of peptide struc-
tures are typically used as a measure of the similarity
between peptide structures derived from a data set.
In the following analysis, the independently deter-
mined structures of the various peptides were super-
imposed upon the 43 mer and the average rmsd of
the backbone atoms determined. The values deter-
mined by superposition of independent peptides can
be compared to the average rmsd determined within
the structural family of a single peptide.
Superposition of residues 15^29 (330^344) of the
Fig. 2. Distribution of the NOE-derived constraints, as a func-
tion of amino acid in the primary sequence of non-phosphoryl-
ated peptide and the phosphorylated peptides which contain the
19 carboxyl terminal amino acid residues of bovine rhodopsin,
330^348: ¢lled bars, intraresidue; cross-hatched bars, sequen-
tial ; open bars, long range. (A) Non-phosphorylated peptide.
(B) One residue phosphorylated (Ser-343 in rhodopsin). (C)
Three residues phosphorylated (Ser-343, Ser-348 and Ser-334).
(D) Seven residues phosphorylated (334, 335, 336, 338, 340,
342, 343).
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33 mer on the corresponding residues of the 43 mer
is characterized by a rmsd of the backbone of 2.1 Aî .
The average rmsd of the backbone atoms for a
superposition of residues 5^15 of the 19 mer on the
corresponding residues of the 43 mer is 2.2 Aî . The
sequence of 5^15 on the 19 mer (334^344) was cho-
sen for this analysis to avoid the disordered ends of
the smaller peptide, yet still contain the L-sheet and
the turn in the structure, as well as the major phos-
phorylation sites. A similar comparison between the
19 mer and the 33 mer gives a rmsd of the backbone
of 2.4 Aî . These rmsd values can be compared to
those obtained for the family of peptide structures
and presented in Fig. 4. This shows that the rmsd
among the three peptides is only slightly higher than
the rmsd obtained (typically 1.5^2) for the family of
structures of a single peptide. Thus the structure of
the 19 mer is similar to the 33 mer and the 43 mer in
the region of interest. The similarities in structure
show that major structural features of the longer
peptides are retained in the shorter peptide. This is
consistent with the established importance of short-
range interactions as determining factors of protein
structure.
Because the 19 mer is structurally similar to the
longer peptides, the e¡ect of phosphorylation on the
structure of the 19 mer is likely relevant to structural
e¡ects of phosphorylation on the larger species.
Although it is possible under in vitro conditions to
phosphorylate all serine and threonine residues in the
carboxyl terminal sequence of rhodopsin [24], under
physiological conditions only a small number of
these residues become phosphorylated [8]. One of
the ¢rst residues to become phosphorylated is Ser-
343 [2,25,26]. Therefore the monophosphopeptide in
which Ser-343 was phosphorylated was synthesized
as an appropriate model to investigate the structural
e¡ect of such a modi¢cation. Phosphopeptides with
additional phosphorylation corresponding to the
three residues Ser-343, Ser-338 and Ser-334, and cor-
responding to the seven residues including all the
serines and threonines in this segment of the protein
(residues 334, 335, 336, 338, 340, 342, 343) were then
6
Fig. 3. Overlay of the six best structures for the non-phos-
phorylated peptide and the phosphorylated peptides which con-
tain the 19 carboxyl terminal amino acid residues of bovine
rhodopsin. These structures were determined by NMR in aque-
ous solution, using methods describe in the text. These are en-
ergy minimized DIANA structures overlaid to show the extent
of agreement among each family of structures. (A) Non-phos-
phorylated peptide. (B) One residue phosphorylated (Ser-343 in
rhodopsin). (C) Three residues phosphorylated (Ser-343, Ser-348
and Ser-334). (D) Seven residues phosphorylated (334, 335, 336,
338, 340, 342, 343).
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investigated to determine the structural e¡ect of
more extensive phosphorylation. The structures of
three phosphorylated derivatives of the 19 mer were
determined as described above for the 19 mer. Figs.
2^4 show these results.
The structures of the unphosphorylated peptide
and the three phosphopeptides were compared by
superposition of the average structures of the fami-
lies, as described above for the unphosphorylated
19 mer and the larger peptides. For the 19 mer
with one phosphate, superposition on the 43 mer
gives a rmsd of the backbone of 4.2 Aî . Superposition
of the 19 mer with one phosphate on the 19 mer with
no phosphates shows an rmsd of 4.3 Aî . Superposi-
tion of the 19 mer with three phosphates on the
43 mer shows a rmsd of 4.2 Aî . Superposition of
the 19 mer with three phosphates on the 19 mer
with one phosphate shows a rmsd of 2.1 Aî . The
19 mer with seven phosphates shows an rmsd of
3.4 Aî with respect to the 43 mer, and an rmsd of
4.5 Aî with respect to the 19 mer with one phosphate
and an rmsd of 4.1 Aî with respect to the 19 mer with
three phosphates. The structural analysis here sug-
gests that the deviations in structure between any
of the phosphorylated derivatives and the unphos-
phorylated 43 mer are substantially greater than
the deviations in structure between the unphosphory-
lated 19 mer and the unphosphorylated 43 mer. The
latter might be taken as the ‘noise level’ in this struc-
tural ‘experiment’. This noise level may represent the
degree of agreement feasible between these kinds of
solution structure determinations of small peptides
and larger, better ordered peptides containing the
same sequence as part of their structure. This analy-
sis further shows that while the addition of one phos-
phate induces a conformational change, the addition
of two more phosphates does not introduce any fur-
ther conformational change. The conformational
change that is induced by these lower levels of phos-
phorylation re£ects a twisting of the L-sheet relative
to the unphosphorylated peptides. Fig. 5 shows this
twist. It is interesting to note that, although not
likely physiological, the addition of seven phosphates
causes a di¡erent conformational change, in which
the L-sheet is broken (the interstrand hydrogen
bonds are broken), but the turn that leads to the
antiparallel strands is still observed.
Fig. 4. Root mean square deviations (RMSD) for the families
of structures in Fig. 3. Statistics graphed by amino acid posi-
tion for all of the backbone atoms in the structure. Statistics
were obtained from X-PLOR. (A) Non-phosphorylated peptide.
(B) One residue phosphorylated (Ser-343 in rhodopsin). (C)
Three residues phosphorylated (Ser-343, Ser-348 and Ser-334.
(D) Seven residues phosphorylated (334, 335, 336, 338, 340,
342, 343).
6
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While it may be argued that phosphorylation may
induce a conformational change on an adjacent loop,
this is unlikely. The phosphorylation sites are well
exposed and are oriented away from other portions
of the protein. Furthermore, studies of phosphoryla-
tion e¡ects on structure of another proteins have
indicated conformational changes are localized near
the residue which is phosphorylated [27]. This anal-
ysis suggests that the addition of one phosphate by
rhodopsin kinase may introduce a conformation
change in the carboxyl terminal detectable by trans-
ducin. Since the ¢rst phosphate appears to produce
just as great a conformational change as an addi-
tional two phosphates appear to do, any further di-
minution of the ability of the G-protein to bind with
increased phosphorylation of rhodopsin may be due
to the increase in negative charge from the additional
phosphates rather than to a change in conformation.
In this context, it is interesting that the introduction
of only a single phosphate is su⁄cient in vivo to
facilitate the binding and activation of arrestin which
initiates shut-o¡ of the visual transduction cascade
[28]. Therefore, the initial twisting of the L-sheet in-
duced by phosphorylation at one site may be an
important factor in arrestin binding.
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